02.20.15
Xerox’s board of directors announced that Stephen H. Rusckowski has been elected to the board effective Feb. 19, 2015.
“Steve has shown impressive leadership at Quest, delivering value in everything he has touched,” said Ursula Burns, Xerox chairman and CEO. “His vision of empowering better health with diagnostic insights and his focus on collaboration within the healthcare industry will be a guide for us as we continue to grow Xerox’s business around the world.”
Rusckowski, 57, is president and chief executive officer of Quest Diagnostics, a position he was named to in 2012. Prior to joining Quest, Rusckowski was CEO of Philips Healthcare. He joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard/Agilent Technologies.
Rusckowski serves as chairman of the American Clinical Laboratory Association, the nation’s leading advocacy organization for the clinical laboratory industry. In addition, he serves on the board of Project Hope, a global health education and humanitarian assistance organization.
“Steve has shown impressive leadership at Quest, delivering value in everything he has touched,” said Ursula Burns, Xerox chairman and CEO. “His vision of empowering better health with diagnostic insights and his focus on collaboration within the healthcare industry will be a guide for us as we continue to grow Xerox’s business around the world.”
Rusckowski, 57, is president and chief executive officer of Quest Diagnostics, a position he was named to in 2012. Prior to joining Quest, Rusckowski was CEO of Philips Healthcare. He joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard/Agilent Technologies.
Rusckowski serves as chairman of the American Clinical Laboratory Association, the nation’s leading advocacy organization for the clinical laboratory industry. In addition, he serves on the board of Project Hope, a global health education and humanitarian assistance organization.